NASDAQ:AVBP | Profit Breakdown | ArriVent BioPharma, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2023-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$52.69M-$49.89M
2026-03-31-$46.11M-$43.32M
2025-12-31-$38.82M-$35.54M
2025-09-30-$38.32M-$34.98M
2025-06-30-$33.62M-$31.4M
2025-03-31-$66.77M-$64.39M
2024-12-31-$23.71M-$20.63M
2024-09-30-$24.23M-$20.56M
2024-06-30-$25.7M-$21.87M
2024-03-31-$20.67M-$17.42M
2023-12-31-$23.12M-$21.19M
2023-09-30-$16.72M-$14.4M
2023-06-30-$22.58M-$21.57M
2023-03-31-$12.17M-$12.17M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$177.53M-$166.31M
2024-12-31-$94.31M-$80.49M
2023-12-31-$74.59M-$69.33M